在炎症性肠病中实现可持续性
Olga Maria Nardone1, Beatriz Gros2,3, Tommaso Lorenzo Parigi4,5
1Gastroenterology, Department of Public Health, University Federico II of Naples, Naples, Italy.
Journal of Crohn's & colitis
|February 19, 2026
概括
可持续的炎症性肠病 (IBD) 护理平衡了患者的结果与可行性,可负担性和环境影响. 本综述探讨了减少IBD的方法.
科学领域:
- 胃肠道学和环境健康
背景情况:
- 全球炎症性肠病 (IBD) 负担正在增加,特别是在低收入国家.
- 在IBD护理中加强监测和治疗到目标策略,引发了对可持续性的担忧.
- 目前的IBD管理可能会增加成本,治疗负担和环境影响.
研究的目的:
- 为了检查炎症性肠病 (IBD) 护理的环境足迹.
- 探索IBD管理中的可持续性的多方面的概念,包括临床,财务,公平和环境因素.
- 在可持续的医疗保健模式中,确定减少伤害和提高患者结果的策略.
主要方法:
- 这项研究是一篇叙事性综述.
- 它综合了有关IBD护理,可持续性和环境影响的当前文献.
- 讨论了可持续IBD管理的关键战略.
主要成果:
- 实现IBD护理的可持续性需要以患者为中心的方法.
- 将临床有效性与可行性,负担能力和环境责任相平衡至关重要.
- 密集的IBD管理策略可能会对环境产生重大影响.
结论:
- 可持续的IBD护理对于应对日益增长的全球负担和医疗保健系统压力至关重要.
- 需要一个协调的,基于证据的方法来支持患者健康和地球福祉.
- 实施可持续实践可以保护和潜在地提高患者的结果,同时尽量减少对生态的伤害.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
940
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
940
Inflammatory Bowel Disease IV: Pharmacological Management
817
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
817
Inflammatory Bowel Disease V: Surgical Management
731
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
731
Inflammatory Bowel Disease II: Crohn's Disease
1.3K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Inflammatory Bowel Disease I: Ulcerative Colitis
1.2K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
574
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
574


